A phenotypic-transport model of selection and therapy-associated phenotypic redistribution in the VC-Resist glioblastoma state
Glioblastoma recurrence is sustained by tumour cells that survive chemoradiation and infiltrate the peritumoural brain. We previously identified VC-Resist, a Nestin-high, vessel-co-opting and therapy-resistant state induced by DNA-damaging therapy and vascular cues. Whether its short-term enrichment reflects selection of pre-existing cells, phenotypic redistribution, or both remains unclear because death, proliferation and state transitions co-occur. We formulate a phenotypic-transport model for glioblastoma-cell density along a continuous Nestin-reporter axis. The model separates phenotype-dependent net growth from conservative transport and is calibrated to seven-day flow-cytometric Nestin distributions after irradiation of MGG4 cells, with Sytox measurements informing treatment-associated death. It reproduces dose-dependent Nestin-high enrichment and is consistent with a graded association between higher Nestin expression, reduced proliferation and greater radiation resistance. Under the specified uncertainty ranges, transport parameters are among the strongest determinants of the modelled day-7 mean Nestin coordinate. Because the velocity field is inferred from the distributions being fitted, independent longitudinal data and transition-specific perturbations are needed to establish whether the redistribution depends causally on therapy-induced reprogramming. Counterfactual simulations compare attenuation of phenotypic transport with reduction of Nestin-associated protection. Our framework provides an interpretable, data-constrained basis for designing experiments that directly test therapy-induced plasticity in glioblastoma.
Authors
- Gabriel F. Calvo (ORCID: https://orcid.org/0000-0002-3623-236X)
- Carmen Ortega-Sabater (ORCID: https://orcid.org/0000-0002-5469-1009)
- Giorgio Seano (ORCID: https://orcid.org/0000-0002-7294-302X)
- Juan Jiménez-Sánchez (ORCID: https://orcid.org/0000-0001-5478-3416)
- Cathy Pichol-Thievend
- José Antonio Romero-Rosales (ORCID: https://orcid.org/0000-0001-5154-3740)
- Juliette Reveilles (ORCID: https://orcid.org/0000-0002-1307-2367)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Spanish National Cancer Research Centre (ES)
- Servicio de Salud de Castilla La Mancha (ES)
- University of Castilla-La Mancha (ES)
- Institut Curie (FR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41598-026-80612-z
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fondation ARC pour la Recherche sur le Cancer
- Ministerio de Ciencia e Innovación
- Junta de Comunidades de Castilla-La Mancha
- European Regional Development Fund
- Agencia Estatal de Investigación